Oruka Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Oruka Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • Oruka Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 3.28K %, a 14.7% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 3.28K +421 +14.7% Jun 30, 2024
Q1 2024 3.2K +726 +29.4% Mar 31, 2024
Q4 2023 3.53K +1.38K +63.9% Dec 31, 2023
Q3 2023 3.29K +1.49K +82.7% Sep 30, 2023
Q2 2023 2.86K +1.12K +64.4% Jun 30, 2023
Q1 2023 2.47K +720 +41.1% Mar 31, 2023
Q4 2022 2.16K +289 +15.5% Dec 31, 2022
Q3 2022 1.8K -35.9 -1.96% Sep 30, 2022
Q2 2022 1.74K -291 -14.3% Jun 30, 2022
Q1 2022 1.75K -221 -11.2% Mar 31, 2022
Q4 2021 1.87K +259 +16.1% Dec 31, 2021
Q3 2021 1.83K +226 +14.1% Sep 30, 2021
Q2 2021 2.03K +1.21K +148% Jun 30, 2021
Q1 2021 1.97K +1.16K +142% Mar 31, 2021
Q4 2020 1.61K +794 +97.3% Dec 31, 2020
Q3 2020 1.61K +806 +101% Sep 30, 2020
Q2 2020 819 +20.2 +2.53% Jun 30, 2020
Q1 2020 815 -3.55 -0.43% Mar 31, 2020
Q4 2019 816 -17.3 -2.07% Dec 31, 2019
Q3 2019 802 +56.6 +7.59% Sep 30, 2019
Q2 2019 799 +103 +14.9% Jun 30, 2019
Q1 2019 818 +162 +24.7% Mar 31, 2019
Q4 2018 833 +158 +23.3% Dec 31, 2018
Q3 2018 745 +0.28 +0.04% Sep 30, 2018
Q2 2018 695 -157 -18.4% Jun 30, 2018
Q1 2018 656 -392 -37.4% Mar 31, 2018
Q4 2017 675 -523 -43.6% Dec 31, 2017
Q3 2017 745 -819 -52.4% Sep 30, 2017
Q2 2017 852 -1.17K -57.8% Jun 30, 2017
Q1 2017 1.05K -1.35K -56.3% Mar 31, 2017
Q4 2016 1.2K -1.4K -53.9% Dec 31, 2016
Q3 2016 1.56K -640 -29% Sep 30, 2016
Q2 2016 2.02K +112 +5.88% Jun 30, 2016
Q1 2016 2.4K +969 +67.9% Mar 31, 2016
Q4 2015 2.6K +967 +59.3% Dec 31, 2015
Q3 2015 2.2K +582 +35.8% Sep 30, 2015
Q2 2015 1.91K +228 +13.6% Jun 30, 2015
Q1 2015 1.43K -466 -24.6% Mar 31, 2015
Q4 2014 1.63K +57.2 +3.63% Dec 31, 2014
Q3 2014 1.62K -139 -7.89% Sep 30, 2014
Q2 2014 1.68K +253 +17.7% Jun 30, 2014
Q1 2014 1.89K +1.18K +165% Mar 31, 2014
Q4 2013 1.57K +722 +84.8% Dec 31, 2013
Q3 2013 1.76K +940 +114% Sep 30, 2013
Q2 2013 1.43K +616 +75.9% Jun 30, 2013
Q1 2013 713 -111 -13.5% Mar 31, 2013
Q4 2012 852 Dec 31, 2012
Q3 2012 822 Sep 30, 2012
Q2 2012 811 Jun 30, 2012
Q1 2012 824 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.